A case of cytomegalovirus retinitis after chemotherapy of Burkitt’s lymphoma

doi:10.3877/cma.j.issn.1674-1358.2019.06.011

Abstract

Abstract:

Objective

To improve the awareness of cytomegalovirus retinitis after chemotherapy of Burkitt’s lymphoma.

Methods

The diagnosis and treatment of one 58-year-old patient of cytomegalovirus retinitis after chemotherapy of Burkitt’s lymphoma was analyzed and relevant literatures were reviewed.

Results

The condition of this patient with Burkitt’s lymphoma was relieved after multicourse chemotherapy, but immune system reconstruction failed due to long-term malnutrition and low resistibility, which led to cytomegalovirus infection and cytomegalovirus retinitis. After antiviral treatment with ganciclovir injection, cytomegalovirus DNA was negative and the vision gradually improved.

Conclusions

Timely diagnosis and standard treatment are the keys to control cytomegalovirus retinitis after immunochemotherapy of Burkitt’s lymphoma.

Key words: Burkitt’s lymphoma, Cytomegalovirus retinitis, Chemotherapy

Xuanyong Liu, Zhi Guo, Liqiong Jiang, Liping Chen, Lina Chen. A case of cytomegalovirus retinitis after chemotherapy of Burkitt’s lymphoma[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2019, 13(06): 515-518.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsyhlcgrbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-1358.2019.06.011

https://zhsyhlcgrbzz.cma-cmc.com.cn/EN/Y2019/V13/I06/515

Figures/Tables 2

References 20

[1]	Bobillo S, Abrisqueta P, Sánchez-González B, et al. Posttransplant monomorphic Burkitt’s lymphoma: clinical characteristics and outcome of a multicenter series[J]. Ann Hematol,2018,97(12):2417- 2424.
[2]	Ribrag V, Koscielny S, Bosq J, et al. Rituximab and dose-dense chemotherapy for adults with Burkitt’s lymphoma: a randomised, controlled, open-label, phase 3 trial[J]. Lancet,2016,387(10036):2402- 2411.
[3]	杨丹，王普，陈佳, 等. COPADM方案治疗20例伯基特淋巴瘤患者远期疗效分析[J]. 中华血液学杂志,2018,39(8):645-649.
[4]	李永新，尹青松，艾昊, 等. 利妥昔单抗联合改良NHL-BFM-90方案对儿童及青少年伯基特淋巴瘤的远期疗效[J]. 中华医学杂志,2019,99(8):605-610.
[5]	Shapira Y, Mimouni M, Vishnevskia-Dai V. Cytomegalovirus retinitis in HIV-negative patients-associated conditions, clinical presentation, diagnostic methods and treatment strategy[J]. Acta Ophthalmol,2018,96(7):e761-e767.
[6]	郭智，陈惠仁，杨凯, 等. 单倍型异基因造血干细胞移植后发生巨细胞病毒感染的临床分析[J]. 国际病毒学杂志,2016,23(3):164-167.
[7]	苗恒，侯婧. 异基因造血干细胞移植术后巨细胞病毒视网膜炎治疗过程的影响因素分析[J]. 中华眼科杂志,2017,53(10):740-745.
[8]	Fujita N, Kobayashi R, Atsuta Y, et al. Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma[J]. Int J Hematol,2019,109(4):483- 490.
[9]	张梦，金玲，杨菁, 等. 儿童伯基特淋巴瘤186例临床特征及疗效分析[J]. 中华儿科杂志,2018,56(8):605-610.
[10]	孙挥宇，毛菲菲，李丹, 等. 未经抗巨细胞病毒治疗时艾滋病合并巨细胞病毒性视网膜炎的临床特征及其预后[J]. 眼科,2016,25(3):195-198.
[11]	Port AD, Orlin A, Kiss S, et al. Cytomegalovirus retinitis: a review[J]. J Ocul Pharmacol Ther,2017,33(4):224-234.
[12]	Chiotan C, Radu L, Serban R, et al. Cytomegalovirus retinitis in HIV/AIDS patients[J]. J Med Life,2014,7(2):237-240.
[13]	覃海明，农影星. AIDS合并巨细胞病毒性视网膜炎60例临床观察[J]. 国际眼科杂志,2016,16(9):1702-1704.
[14]	邵玲，杜敏，付淑凤, 等. 玻璃体腔注射更昔洛韦治疗巨细胞病毒性视网膜炎的疗效观察[J/CD]. 中华眼科医学杂志(电子版),2015,5(6):309-313.
[15]	郭智，陈惠仁，刘晓东, 等. 异基因造血干细胞移植后发生巨细胞病毒感染的临床分析[J]. 中国实验血液学杂志,2012,20(4):971-974.
[16]	张雨，曾慧慧. 人巨细胞病毒感染及母婴传播阻断临床研究进展[J/CD]. 中华实验和临床感染病杂志(电子版),2017,11(6):526-532.
[17]	李丹，孙挥宇，毛菲菲, 等. 获得性免疫缺陷综合征患者巨细胞病毒性视网膜炎相关免疫重建炎症综合征的临床观察[J/CD]. 中华实验和临床感染病杂志(电子版),2014,8(3):363-367.
[18]	Chan ST, Logan AC. The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters[J]. Blood Rev,2017,3l(3):173-183.
[19]	邹明，张军军. 全身应用糖皮质激素加重巨细胞病毒性视网膜炎1例[J]. 国际眼科杂志,2012,12(4):807-808.
[20]	刘彬彬，柳月红，许雪静, 等. 光学相干断层扫描在巨细胞病毒性视网膜炎治疗中的应用[J/CD]. 中华实验和临床感染病杂志(电子版),2017,11(4):413-416.

Please choose a citation manager

Content to export